EPH Receptor A8 抗体 (AA 70-150)
Quick Overview for EPH Receptor A8 抗体 (AA 70-150) (ABIN4901461)
抗原
See all EPH Receptor A8 (EPHA8) 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
- 
    - 
                                            抗原表位
- AA 70-150
- 
                                            原理
- Mouse monoclonal to EphA8.
- 
                                            特异性
- EphA8 Monoclonal Antibody detects endogenous levels of EphA8 protein.
- 
                                            产品特性
- Mouse Monoclonal to EphA8.
- 
                                            纯化方法
- Affinity purification
- 
                                            免疫原
- Purified recombinant fragment of EphA8 (aa70-150) expressed in E. Coli.
- 
                                            亚型
- IgG1
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- 
                        WB 1:500-1:2000
 ELISA 1:10000
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            缓冲液
- Ascitic fluid containing 0.03 % sodium azide.
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            注意事项
- Avoid repeated freeze/thaw cycles.
- 
                                            储存条件
- -20 °C
- 
                                            储存方法
- Store at -20°C, and avoid repeat freeze-thaw cycles.
 
- 
                                            
- 
    - EPH Receptor A8 (EPHA8)
- 
                                            别名
- EphA8
- 
                                            基因ID
- 2046
- 
                                            UniProt
- P29322
- 
                                            途径
- RTK signaling
 抗原
- 
                    
 
                                     
                                     
                                    